Last reviewed · How we verify
NCT07153185
Creos Xenoprotect PMCF
trial testing Dental Barrier Membrane in Bone Regeneration in 200 participants. Not yet recruiting.
31 July 2026
Quick facts
| Lead sponsor | Nobel Biocare |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 November 2025 |
| Primary completion | 31 July 2026 |
| Estimated completion | 31 July 2026 |
Drugs / interventions tested
- Dental Barrier Membrane
Conditions studied
- Bone Regeneration — all drugs for Bone Regeneration →
- Dental Implants — all drugs for Dental Implants →
- Bone Grafting — all drugs for Bone Grafting →
Sponsor
Nobel Biocare
Who can join
18 and older, any sex, with Bone Regeneration or Dental Implants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this retrospective PMCF study is to assess safety and performance of creos xenoprotect in all indications functioning as dental barrier membrane. The primary endpoint of the study is the occurrence of major complications during 6 months after creos xenoprotect placement whereas the hypothesis is that these major complications occur in less than 5% within this timeframe. This is a retrospective, multicenter clinical investigation with consecutive cases. Data will be collected on consecutive data cases from patient files, given that these patients were treated within a defined indication with creos xenoprotect in the past. Patients participating in this study do not have any obligations or need to come back for any intervention. A total of 11 centers are planned to be included. Sample size is n=200 patients and is distributed equally in four indication groups: Group 1: Ridge augmentation (vertical and horizontal) Group 2: Alveolar ridge preservation Group 3: Sinus floor augmentation Group 4: Augmentation around implant or teeth
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07153185
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Regeneration
Currently open trials in the same condition.
- NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
- NCT06383377 — Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investi · NA · recruiting
Other Nobel Biocare trials
Trials by the same sponsor.
- NCT07258940 — NobelZygoma TiUltra Implant System Study · NA · not yet recruiting
- NCT06600451 — A Retrospective Data Collection on NobelProcera® Zirconia Implant Bridges from 4 to 14 Units. · active not recruiting
- NCT04737421 — A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components · active not recruiting
- NCT04736771 — Study Assessing the Safety and Effectiveness of the Nobel Biocare N1 Concept System. · completed
- NCT03100448 — A 1-year Clinical Investigation on the On1 Concept · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07153185 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nobel Biocare
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07153185.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing